04.28.15
INC Research
1Q Revenues: $211.5 million (+15%)
1Q Earnings: $25.3 million (loss of $1.7 million 1Q14)
Comments: New business awards were $255.5 million in the quarter, as compared to $280.9 million in 1Q14, and a book-to-bill ratio of 1.2x. Service revenue was $211.5 million in the quarter, up 15%, with particularly strong growth in CNS, Oncology and other complex therapeutic areas.
1Q Revenues: $211.5 million (+15%)
1Q Earnings: $25.3 million (loss of $1.7 million 1Q14)
Comments: New business awards were $255.5 million in the quarter, as compared to $280.9 million in 1Q14, and a book-to-bill ratio of 1.2x. Service revenue was $211.5 million in the quarter, up 15%, with particularly strong growth in CNS, Oncology and other complex therapeutic areas.